0001062993-18-001883.txt : 20180502
0001062993-18-001883.hdr.sgml : 20180502
20180502124036
ACCESSION NUMBER: 0001062993-18-001883
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20180502
DATE AS OF CHANGE: 20180502
EFFECTIVENESS DATE: 20180502
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xanthic Biopharma Inc.
CENTRAL INDEX KEY: 0001739376
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-311493
FILM NUMBER: 18798578
BUSINESS ADDRESS:
STREET 1: 2100 BLOOR ST. WEST, SUITE 6339
CITY: TORONTO
STATE: A6
ZIP: M6S 5A5
BUSINESS PHONE: 647-341-8033
MAIL ADDRESS:
STREET 1: 2100 BLOOR ST. WEST, SUITE 6339
CITY: TORONTO
STATE: A6
ZIP: M6S 5A5
D
1
primary_doc.xml
X0708
D
LIVE
0001739376
Xanthic Biopharma Inc.
2100 BLOOR ST. WEST, SUITE 6339
TORONTO
A6
ONTARIO, CANADA
M6S 5A5
647-341-8033
ONTARIO, CANADA
Aurquest Resources Inc.
None
Corporation
true
David
Bhumgara
2100 Bloor St. West, Suite 6339
Toronto
A6
ONTARIO, CANADA
M6S 5A5
Executive Officer
Tim
Moore
2100 Bloor St. West, Suite 6339
Toronto
A6
ONTARIO, CANADA
M6S 5A5
Executive Officer
Director
Gary
Galitsky
2100 Bloor St. West, Suite 6339
TORONTO
A6
ONTARIO, CANADA
M6S 5A5
Executive Officer
Director
Dr. Shafik
Dharamshi
2100 Bloor St. West, Suite 6339
TORONTO
A6
ONTARIO, CANADA
M6S 5A5
Director
Dr. Gunter
Hintz
2100 Bloor St. West, Suite 6339
TORONTO
A6
ONTARIO, CANADA
M6S 5A5
Director
Carli
Posner
2100 Bloor St. West, Suite 6339
TORONTO
A6
ONTARIO, CANADA
M6S 5A5
Director
David
Lubotta
2100 Bloor St. West, Suite 6339
Toronto
A6
ONTARIO, CANADA
M6S 5A5
Director
Peter
Schwartz
2100 Bloor St. West, Suite 6339
Toronto
A6
ONTARIO, CANADA
M6S 5A5
Director
Other
Decline to Disclose
- 06b
false
2018-04-19
false
true
true
true
true
Units consisting of 1 cmn share & 1/2 cmn share purchase warrant, each whole warrant is exercisable for CAD$0.75 per share for 24 months post closing.
false
0
34632
19790
14842
Units consisting of 1 cmn share & 1/2 cmn share purchase warrant, each whole warrant is exercisable for CAD $0.75 per share for 24 months post closing.
false
1
0
0
0
false
Xanthic Biopharma Inc.
/s/ David Bhumgara
David Bhumgara
Chief Financial Officer
2018-04-30